KEGG   DRUG: D06621Help
Entry
D06621                      Drug                                   

Name
Motavizumab (USAN/INN);
MEDI-524
Formula
C6476H10014N1706O2008S48
Exact mass
145346.0521
Mol weight
145436.1498
Activity
Prevention of serious lower respiratory tract disease caused by respiratory syncytial virus (RSV) in pediatric patients at high risk of RSV disease [DS:H00401]
Remark
ATC code: 
Target
RSV F protein
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 J ANTIINFECTIVES FOR SYSTEMIC USE
  J06 IMMUNE SERA AND IMMUNOGLOBULINS
   J06B IMMUNOGLOBULINS
    J06BB Specific immunoglobulins
     J06BB17 Motavizumab
      D06621  Motavizumab (USAN/INN)
BRITE hierarchy
Other DBs
CAS: 
677010-34-3
PubChem: 
LinkDB All DBs

» Japanese version   » Back

DBGET integrated database retrieval system